Intrinsiqq
European Medical Solutions S.A. logo

European Medical Solutions S.A. Financials

ALEMS.XBRU

Compare

All currency values in € millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue€50€45€41€35€36
Cost of Revenue€33€30€27€23€24
Gross Profit€16€15€14€12€12
Total Operating Expenses€14€14€13€14€12
Operating Income€3€1€0-€2€0
Non-Operating
Net Interest Expense-€1-€1-€0-€0-€0
Income Tax Expense€0€0€0-€0-€0
Net Income
Net Income€2€1-€1-€6-€0
Per Share Data
Revenue Per Share€11.80€10.48€9.42€8.23€529.75
EPS (Basic)€0.43€0.13-€0.17-€1.30-€3.52
EPS (Diluted)€0.43€0.13-€0.17-€1.30-€3.52
Shares Outstanding4.2M4.3M4.3M4.3M68,465.909
Dividends Per Share––––€7.61

European Medical Solutions (ALEMS.XBRU) financials: revenue, profit and margins

European Medical Solutions (ALEMS.XBRU) generated about €50 million in revenue and €2 million in net income (a 3.7% net margin) over the trailing twelve months, growing at roughly 8.3% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is European Medical Solutions's (ALEMS.XBRU) revenue?+

European Medical Solutions generated about €50 million in revenue over the trailing twelve months. Revenue has grown at roughly 8.3% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is European Medical Solutions profitable?+

Yes, European Medical Solutions reported about €2 million in net income over the trailing twelve months, a net profit margin of roughly 3.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are European Medical Solutions's profit margins?+

European Medical Solutions runs a gross margin of about 32.9%, an operating margin of about 5.4%, a net margin of about 3.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is European Medical Solutions growing?+

European Medical Solutions's revenue has compounded at roughly 8.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ALEMS.XBRU's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with ALEMS.XBRU

CompareIntrinsic value
HYL.XBRUHyloris Pharmaceuticals SA
€4.15-3.49%46
ALDMS.XPARDiagnostic Medical Systems S.A.
€0.89-0.67%30
LIK.XETRLimes Schlosskliniken AG
€580.00-1.69%65
IMCCIM Cannabis Corp.
$0.51+8.52%30
NORDH.XOSLNordhealth AS
€2.34-0.85%48
ENZY.XSTOEnzymatica AB
€0.18-4.59%25
SCIB.XSTOSciBase Holding AB
€0.71-0.56%40
SDOS.XSTOScandiDos AB
€0.01-20.00%25

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALEMS.XBRU

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.